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Urinary exosomes are 40–100nm vesicles containing protein,
mRNA, and microRNA that may serve as biomarkers of renal
dysfunction and structural injury. Currently, there is a need
for more sensitive and specific biomarkers of renal injury and
disease progression. Here we sought to identify the best
exosome isolation methods for both proteomic analysis and
RNA profiling as a first step for biomarker discovery. We used
six different protocols; three were based on ultracentrifugation,
one used a nanomembrane concentrator–based approach,
and two utilized a commercial exosome precipitation
reagent. The highest yield of exosomes was obtained using a
modified exosome precipitation protocol, which also yielded
the highest quantities of microRNA and mRNA and,
therefore, is ideal for subsequent RNA profiling. This method
is likewise suitable for downstream proteomic analyses if an
ultracentrifuge is not available and/or a large number of
samples are to be processed. Two of the ultracentrifugation
methods, however, are better options for exosome isolation
if an ultracentrifuge is available and few samples will be
processed for proteomic analysis. Thus, our modified
exosome precipitation method is a simple, fast, highly
scalable, and effective alternative for the isolation of
exosomes, and may facilitate the identification of exosomal
biomarkers from urine.
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Chronic kidney disease is a major complication of diabetes
mellitus, hypertension, and glomerulonephritis that is char-
acterized by a progressive deterioration of renal function. The
disease is typically diagnosed by the presence of increased
levels of either urinary albumin or serum creatinine, although
neither measure can accurately indicate the type of renal
injury.1 In addition, significant renal disease can be present
with minimal/no change in creatinine1,2 or albumin3,4 levels.
Thus, the modest diagnostic value of albumin and creatinine
levels underscores the need for more sensitive and specific
markers of renal injury, particularly ones that correlate with
early fibrosis and disease progression.
Biomarkers serve as indicators of normal biological
processes, pathological developments, or pharmacological
response to a therapeutic intervention. Good biomarkers are
sensitive, specific, relatively noninvasive, and efficiently assayed
using a fast and relatively inexpensive method.1 Urine is an
ideal source of biomarkers, particularly for diseases of the
kidney and urinary tract,1,5 because it can be conveniently
collected in large amounts without risk to the patient. In
addition to hundreds of proteins (albeit at low concentrations),
urine also contains 40–100nm vesicles known as exosomes,
which are normally secreted by cells from all nephron
segments,6,7 and may carry protein, mRNA, and microRNA
(miRNA) markers of renal dysfunction and structural injury.
Unlike renal biopsy, an invasive and expensive procedure that
provides only a small sample from one of two kidneys, urinary
exosomes provide a full representation of the entire urinary
system.6
The most widely used method for the isolation of exosomes
from biological fluids, including urine, is based on a two-step
differential centrifugation process.8–11 Although this method
efficiently isolates exosomes from urine, it is time-consuming
and the requirement for expensive equipment, which allows
processing of low volumes of only a few urine samples at a
time, limits its applicability in the clinical setting. Conse-
quently, faster and more efficient methods to isolate exosomes
are needed, and some, including the ones based on
ultrafiltration12,13 and precipitation,14 have already been
developed. Although both ultrafiltration and precipitation
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are faster and easier than ultracentrifugation to implement in
the clinical laboratory, they are not without their own sets of
limitations. For example, highly abundant proteins present in
urine tend to be retained by ultrafiltration and subsequently
interfere with the identification of exosomal proteins.15
Although precipitation has been shown to yield exosomal
RNA and protein with greater purity and quantity than
ultracentrifugation, to date, the utility of this method has only
been demonstrated for the isolation of exosomes from ascites,
and its performance using urine is not yet known.14
The goal of this study, therefore, was to identify the best
isolation methods for both proteomic analysis and RNA
profiling of urinary exosomes as a first step for biomarker
discovery. We followed six different protocols, designated
P1–P6, for the isolation of urinary exosomes, and evaluated
the quantity and purity of exosomal protein and RNA using
each method (Table 1). Three of the tested methods (P1–P3)
were based on ultracentrifugation. P1 was the reference or
standard differential centrifugation method,8 whereas P2 and
P3 included an extra step to increase the purity of the isolated
urinary exosomes. Specifically, P2 incorporated an additional
ultracentrifugation step with a 30% sucrose cushion and
P3 passed preprocessed urine through a 0.22-mm filter just
before ultracentrifugation. We also tested three other
methods that are faster than the ultracentrifugation-based
ones: P4 was based on the use of Vivaspin 20 nanomembrane
ultrafiltration concentrator (Sartorius; Bohemia, NY),12
whereas P5 and P6 utilized the exosome precipitation reagent
ExoQuick-TC (System Biosciences; Mountain View, CA),
which is specific for the isolation of exosomes from both
urine and cell cultures. To our knowledge, this is the first
report that evaluates differences in yield and quality of
exosomal protein, miRNA, and high-molecular weight
(HMW) RNA obtained using multiple methods of exosome
isolation from urine, including two different protocols based
on the ExoQuick-TC reagent.
RESULTS
Reduction of Tamm–Horsfall protein (THP) to increase the
yield of urinary exosomes
We first sought to optimize the overall yield of exosomes from
urine samples. Urine is rich in large amounts of a polymeric
network formed by the Tamm–Horsfall protein (THP), which
traps exosomes during the initial low-speed centrifugation
(17,000 g) of the urine preprocessing stage.16 To account for
this effect and potentially increase exosome yield, we reduced
THP using DL-dithiothreitol during the preprocessing of
urine for P1–P4 and P6 (Figure 1) and the isolation of
exosomes (P1–3, Figure 2), as described in the Materials and
Methods section. As shown in Figure 3a and b, a higher
amount of THP was present in the 17,000 g pellet obtained
from P5, compared with the DL-dithiothreitol-treated proto-
cols. As shown in Figure 3c, a higher amount of THP is
observed in the 17,000 g pellet using P5 compared with P6,
and no THP was present in the supernatant obtained after the
last centrifugation using both protocols.
Quantification of urinary exosome particles
We next quantified the number of urinary exosome particles
using CD9 enzyme-linked immunosorbent assay (ELISA). As
shown in Figure 4a, the highest number of exosome particles
per ml of urine (B2.7 109) was obtained using P6,
followed by P1 and P4. We also found that the yield of
exosome particles per ml of urine was more than five times
higher using the modified ExoQuick-TC (P6) compared with
the standard ExoQuick-TC (P5). The lowest yield of exosome
particles was obtained using P2.
Comparison of yield and purity of exosomal proteins
We next quantified the levels of total exosomal protein
obtained per ml of urine (Figure 4b) and found that
significantly higher (Po0.001) protein yield was obtained
using P4 compared with all other protocols. P6 yielded half of
the total protein observed for P4, but produced more than
sixfold higher amounts of total protein compared with P5
(Figure 4b).
We assessed the purity of exosomal proteins recovered
using each protocol by measuring the content of two
exosomal markers, Alix (apoptosis-linked gene 2–interacting
protein X) and TSG101 (tumor susceptibility gene 101
protein). We found that Alix and TSG101 were detected in
urine samples from four subjects when P1, P2, and P6 were
used to isolate exosomes. However, when P5 was utilized to
isolate exosomes, the proteins were only detected in the most
concentrated urine (Figure 5d), but not in the other samples
(Figure 5a–c). This is likely a consequence of the higher
amount of total soluble protein (TSP) loaded per well in the
gel shown in panel d compared with those shown in the other
panels (457.5 ng TSP/well vs. 305 ng/well or 142.5 ng/well in
the other immunoblots). We also detected Alix and TSG101
only in the two most concentrated urine samples (Figure 5b
and d) using P4. The densitometric analysis of the bands in
the immunoblots corresponding to Alix and TSG101 are
shown in Figure 5e and f.
Quantification of exosomal miRNA and HMW RNA
We next compared yields of miR-192 and miR-1207-5p from
urinary exosomes isolated using each protocol. These
miRNAs have been previously associated with diabetic
nephropathy and are highly expressed in the kidney,17,18
especially in glomerular and proximal tubular epithelial cells,
Table 1 | Exosome isolation protocols
Protocol
name Method
P1 Ultracentrifugation
P2 Ultracentrifugation+30% sucrose cushion
P3 Ultracentrifugation+0.22mm filtration
P4 Nanomembrane ultrafiltration concentrator (Vivaspin 20;
Sartorious)
P5 Standard exosome precipitation (ExoQuick-TC; System
Biosciences)
P6 Modified exosome precipitation (ExoQuick-TC; System
Biosciences)
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which normally secrete part of the exosomes found in urine.6
As shown in Figure 6a, the highest levels of miR-1207-5p and
miR-192 were obtained using P6, followed by P1, P2, and P5,
whereas the lowest amounts were found in the methods using
a filtration step (P3–P4).
We also examined mRNA expression of two specific
markers of exosomes (TSG101 and PDCD6IP), as well as
Aquaporin-2 (AQP2), a common marker for various forms
of chronic kidney disease.19–21 As shown in Figure 6b, levels
of all three transcripts were significantly higher (Po0.001)
using P6 compared with the other protocols, including P5.
Summary comparison of P1–P6
Table 2 shows a summary of the comparison among the six
exosome isolation methods tested here. A score from 0
(lowest) to 10 (highest) was arbitrarily assigned to each
method to semiquantify the efficiencies with which exosome
particles, miRNA, HMW RNA, and proteins were obtained
according to the results shown in Figures 4–6. The modified
ExoQuick-TC method (P6) had the highest total score, more
than 0.5-fold higher than the two best ultracentrifugation-
based methods P1 and P2, and fourfold higher than the
standard ExoQuick-TC method (P5).
DISCUSSION
Urinary exosomes containing proteins, mRNAs, and miRNAs
secreted by cells from all nephron segments6,22 provide an
accurate representation of renal dysfunction and structural
injury, and as such may be suitable for the identification of
biomarkers for chronic kidney disease.23 There are several
methods available for the isolation of exosomes from urine,
but very few studies have investigated the comparative
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15 ml (P4), or 10 ml (P6)
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Continue with
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(see Figure 2)
Save for a
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SDS–PAGE (Figure 3)
Continue with
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(see Figure 2)
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with I.S.
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Save for a
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Figure 1 |Urine preprocessing. Urine was centrifuged at 17,000 g (P1, P2, P3, P4, and P6) or at 3000 g (P5) to remove urinary sediment
including whole cells, large membrane fragments, and other debris. To reduce the entrapment of exosomes by Tamm–Horsfall protein, we
dissolved pellets in 500ml isolation solution (I.S.; 250mmol/l sucrose, 10mmol/l triethanolamine, pH 7.6), added 100mg of DL-dithiothreitol
(DTT), and incubated them for 10min at 37 1C, and then centrifuged again at 17,000 g for 10min at 37 1C. The supernatant (second
supernatant (SN2)) from protocols 1, 2, 3, 4, and 6 was combined with SN1 (first supernatant) and processed as summarized in Figure 2. P1,
P2, and P3 are exosome isolation protocols based on ultracentrifugation with either an extra purification step with 30% sucrose cushion (P2)
or a 0.22-mm filtration following the urine preprocessing step (P3). P4 uses the Vivaspin 20 nanomembrane filtration concentrator
(Sartorius), and P5 (standard method) and P6 (modified method) are based on the exosome precipitation reagent ExoQuick-TC (System
Biosciences). PIC, protease inhibitor cocktail (Sigma); SDS–PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis.
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efficiencies of these different methods,6,11,14,15 and most reports
have focused only on proteomic, but not RNA, profil-
ing.8,10,11,13 Only one report has described the isolation and
characterization of nucleic acids from urinary exosomes, but
that work focused solely on mRNA, not miRNA.6 Although
urinary exosomes are a promising source of biomarkers, the
most effective method for their isolation is currently ultra-
centrifugation, a procedure that is time-consuming and requires
expensive equipment.24
The aim of this study, therefore, was to compare the
efficiencies of six different protocols in the isolation of
miRNA, mRNA, and protein from urinary exosomes. In
addition, we wanted to identify a simple, fast, and effective
alternative to ultracentrifugation for the isolation of exosomes
in the clinical setting. The results presented here indicate that
the exosome isolation method based on the commercial
precipitation reagent ExoQuick-TC, which is simple, fast, and
requires just a common centrifuge, yields the highest quantity
and quality of exosomal miRNA and mRNA, but only
following modifications we made to the original protocol
recommended by the manufacturer. To our knowledge, this is
the first investigation of this method in terms of efficiency of
exosome isolation from urine and its comparison with other
methods previously described in the literature.
In the current study, we found that P1, P2, and P6 were the
three protocols that produced the purest exosomal protein
preparations, as evidenced by strong Alix and TSG101 protein
bands, even when low quantities of TSP were loaded per well
(Figure 5). Earlier findings showed that an ultracentrifuga-
tion-based method similar to P1 yielded a protein preparation
with enough purity to perform well in subsequent liquid
chromatography–tandem mass spectrometry analysis,7 which
supports our findings. In contrast, bands corresponding to the
Alix and TSG101 proteins were not detected with the P4 and
P5 methods when low quantities of TSP were loaded per well,
suggesting that these protocols yielded exosomal proteins with
lower purity, possibly resulting from the presence of abundant
soluble proteins, including THP, that were coisolated with
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Concentrate
using Speedvac
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(exosomes)
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(discard)
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Add 25 ml
of I.S.
Add 25 ml of PBS
Load on 30% sucrose cushion
Collect sucrose cushion
Add 25 ml PBS
SN3
(discard)
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0.22 µm
Filtration
500 µl of I.S.
100 mg DTT
10 min, 37 °C
Load on 
filtrator concentrator
Add 2 ml
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Add 3.3 ml
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Figure 2 | Isolation of urinary exosomes. After urine was preprocessed as described in Figure 1, six different protocols were used to isolate
exosomes, three based on ultracentrifugation at 165,000 g (P1, P2, and P3), one on the use of the Vivaspin 20 nanomembrane filtration
concentrator (Sartorius; P4), and two that use the exosome precipitation reagent ExoQuick-TC (System Biosciences); P5 is the standard
method recommended by the manufacturer, whereas P6 is our modification of that method. DTT, DL-dithiothreitol; I.S., isolation solution
(250mM sucrose, 10mM triethanolamine, pH 7.6); PBS, phosphate-buffered saline (0.14 M NaCl, 0.0027 M KCl, 0.010 M PO4
3, pH 7.4);
SDS–PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis; SN, supernatant. Nanomembrane filtration concentrator Vivaspin 20,
100 kDa MWCO (Sartorious; Bohemia, NY).
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the exosomes. This is in agreement with earlier work in which
a large amount of protein reduced the efficiency of ultrafiltra-
tion by obstructing the nanomembrane.15 The exosomal pellet
obtained using P4 was the only one that had a strong yellow
color (data not shown), indicating the presence of con-
taminants, which may compete with exosomal proteins for
detection by mass spectrometry and immunoblotting.5,24
Further, P1 and P2, which yielded the purest preparations
of exosomal proteins, had reduced levels of total proteins
compared with P4 and P6, suggesting lesser contamination
from urine proteins not derived from exosomes and/or a
lower exosomal protein yield. On the basis of these results, P4
and P5 are not expected to perform optimally for subsequent
proteomic analyses.
Recently, an improved ultracentrifugation-based method
that facilitates the removal of major impurities associated
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Figure 3 |Protein electrophoretic patterns of different urinary
fractions. The urinary sediment obtained after the last 17,000 g
spin (protocols P1–P4, and P6) or the first 3000 g spin (P5), with or
without DL-dithiothreitol (DTT) treatment as indicated in the
figure, was resuspended in 30 ml of reduced sample mix and
loaded on a NuPAGE Novex 4–12% Bis-Tris gel and stained with
silver as described in the Materials and Methods section. (a, b)
Analysis of two different spot urine samples provided by two
healthy subjects. One urine sample (a) is more concentrated than
the other one (b), and therefore a lower number of protein bands
are visible in the silver-stained gel. (c) Comparison of exosome
pellet (E), 17,000 g or 3000 g pellet (P; urinary sediment), and the
last supernatant (SN3, Figure 2) obtained using exosome isolation
protocols P5 and P6, which are both based on the exosome
precipitation reagent ExoQuick-TC. The large 85–100-kDa band
corresponds to the Tamm–Horsfall protein (THP) monomer, which
consists of approximately 70% protein and 30% carbohydrate by
weight.27 M, protein molecular marker; U, unprocessed urine.
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Figure 4 |Quantification of the number of exosomal particles
and total exosomal protein. (a) Estimation of exosome particle
number per ml of urine by CD9 enzyme-linked immunosorbent
assay. Bars are mean±s.d. of four different spot urine samples
provided by four healthy subjects. (b) Quantification of total
exosomal proteins per ml of urine by absorbance measurement at
280 nm. **Po0.01; ***Po0.001.
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with urinary exosomes has been reported.25 This method uses
a double-cushion sucrose/D2O centrifugation step to isolate
exosomes without any contamination with THP, and thus
it would be highly recommended to use this method for
protein profiling by mass spectrometry. However, this
method requires an ultracentrifuge, is very time-consuming,
and therefore not apt for the processing of a high number of
samples.
Although P6, the modified ExoQuick-TC method, yielded
only half of the total protein of P4, strong signals for the Alix
and TSG101 proteins nevertheless indicate a high recovery of
exosomal proteins. These results contrasted with the ones
obtained using the standard ExoQuick-TC method, P5,
which showed very low protein yield compared with the
other protocols, as well as very low Alix and TSG101 signals,
suggesting only a modest recovery of total protein and low
purity of exosomal proteins. The presence of THP in the
exosome pellet, but not in the supernatant, of the last
centrifugation step of P5 and P6 (Figure 3c) suggests that the
ExoQuick-TC reagent precipitates not only exosomes but
also THP. Thus, a low-purity exosomal protein preparation
was expected with these two methods, although P6 yielded
stronger Alix and TSG101 bands compared with P5. These
results can be explained by the fivefold higher yield of
exosomes obtained with P6, compared with P5 (Figure 4a),
and thus a higher ratio of exosomal proteins per TSP should
be expected with the former. There are three main differences
between the standard (P5) and the modified (P6) ExoQuick-
TC-based methods that may have contributed to the higher
exosome yield of P6: different preprocessing of the urine
(DL-dithiothreitol was added in P6, but not P5); different
volumes of ExoQuick-TC reagent (3.3ml for P6 vs. 2ml for
P5); and different final centrifugation speeds to pellet
exosomes (1500 g for P5 vs. 10,000 g for P6).
Three different fractions containing proteins, small RNA
(o200 nt), and HMW RNA (4200 nt) were extracted from
exosome pellets isolated using each protocol. High levels of
exosomal miR-192 and miR-1207-5p were obtained only with
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Figure 5 |Purity of the exosomal protein preparations. (a–d) Western blot of exosomal markers Alix (apoptosis-linked gene 2–interacting
protein X) and TSG101 (tumor susceptibility gene 101 protein) isolated using the protocols P1–P6 from four spot urine samples provided
by four healthy subjects. An equal amount (indicated in the figure) of total soluble protein (TSP) was loaded in each lane. (e and f)
Densitometry analysis of Alix and TSG101 immunoblots, respectively. Because equal amounts of TSP were loaded in each well of the gel, the
intensities of the Alix and TSG101 bands are proportional to the purity of the exosomal protein preparation using each individual protocol.
Bars are mean±s.e.m. of four densitometry readings. A.U., arbitrary units.
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P6, but not with any of the remaining protocols, including P5,
which may be due to the higher exosome yield of P6. The
lowest yields were achieved with P3 and P4, which use a
filtration step, and may suffer from nonspecific binding of
the most abundant proteins to the filtration membranes.
This action may affect not only the purity of the exosomal
preparation but also the quality of results from exosomal RNA.
The finding that the highest yield of exosome particles per
ml of urine was obtained using P6 is consistent with the
highest amounts of miR-192, miR-1207-5p, AQP2 mRNA,
TSG101 mRNA, and PDCD6IP (Alix) mRNA also obtained
with this method. Levels of TSG101, ALIX, and AQP2 mRNA
were significantly higher (Po0.001) when P1 or P2 was used
compared with P4, which is in contrast to those previously
reported, showing that ultracentrifugation and ultrafiltration
concentration methods yielded similar levels of total RNA.6
However, that study investigated total RNA concentration
only, which is affected by the presence of contaminants,
instead of levels of specific mRNAs using a highly sensitive
and specific approach such as the TaqMan quantitative PCR
method used in the current study.
Despite the significance of the findings reported here, we
recognize some limitations of this study. First, we tested a
relatively small number of samples, although the size of the
study was comparable with those reported earlier.6,9 Second,
exosomes are typically characterized on the basis of size
(40–100 nm) and shape using transmission electron micro-
scopy.16 Other larger types of microvesicles coisolate with
exosomes using most methods, and only transmission
electron microscopy can distinguish among vesicles. How-
ever, the majority of the microvesicles isolated from urine are
thought to be exosomes,8 and because we also verified the
presence of common exosome-specific proteins (Alix and
TSG101) we do not expect larger microvesicles to contribute
significantly to the findings reported here. Similarly, we also
quantified exosome particles by CD9 ELISA instead of the
more commonly used transmission electron microscopy.
However, CD9 ELISA is a more sensitive and specific method
for the quantification of urinary exosomes, although it only
detects the subpopulation of exosomes derived from the
epithelial cells of thick ascending limb.26 Therefore, CD9
ELISA is more appropriate for a relative quantification of
exosomes among different methods or samples than for
determining the absolute number of exosomes. Another
limitation of this study is that we used only urine samples
from healthy donors, which contain low levels of urinary
proteins. It has been previously demonstrated that methods
based on ultrafiltration (similar to P4) cannot be used to
isolate exosomes from nephrotic urine because the proteins
clog the filter, whereas exosomes isolated using a method
based on ultracentrifugation can be further purified from
urine samples containing high amounts of proteins by using
an extra step of size-exclusion chromatography.15 However,
it is worth noting that the abundant proteins present in
nephrotic urine would not pose a problem if the goal of the
investigation involves either RNA profiling or proteomic
studies using western blot or ELISA.
On the basis of our findings, the selection of an exosome
isolation protocol should take into account the number of
samples to be tested, available equipment, and the type of
analysis to be performed. For example, if the goal is to isolate
urinary exosomes for proteomic analysis by using mass
spectrometry in a low number of samples, and an
ultracentrifuge is available, then either P1 or P2 would be
the best option (high protein score, Table 2). However, if an
ultracentrifuge is not available and/or a high number of
samples will be analyzed, then P6 would be a more suitable
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Figure 6 |Quantification of microRNAs (miRNAs) and mRNAs
in urinary exosomes. (a) Relative levels of exosomal miRNAs
1207-5p and 192 obtained using exosome isolation protocols
P1–P6. Results correspond to a relative quantification of miRNAs
by TaqMan quantitative PCR. The level of each miRNA was relative
to the one obtained using P1, which was arbitrarily considered
as 1. (b) Relative levels of exosomal AQP2 (Aquaporin-2) and the
exosomal markers TSG101 (tumor susceptibility gene 101) and
PDCD6IP (programmed cell death 6–interacting protein or Alix)
mRNA obtained with P1–P6. The significance is indicated only for
methods that are significantly different from all the others.
***Po0.001. A.U., arbitrary units.
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alternative. The yield of exosomal proteins obtained using P6
is good (Figure 4b), although the purity of the preparation
was lower compared with the ultracentrifugation-based
methods P1 and P2 (Figure 5). However, the purity of the
protein yield using P6 could be easily improved with the
inclusion of a simple purification step, such as size-exclusion
chromatography.15 Alternatively, P6 is more highly recom-
mended if the goal of the study is RNA profiling, because this
method yielded higher quantities and better qualities of
exosomal miRNAs and mRNAs compared with all other
methods, including the ultracentrifugation-based ones, which
were heretofore considered the most effective methods for
exosome isolation.8,24
In summary, out of the protocols tested, P6 is the simplest,
fastest, and most effective alternative to ultracentrifugation-
based protocols for the isolation of urinary exosomes,
particularly for RNA profiling, making it suitable for the
rapid assessment of biomarkers in a large number of clinical
samples. This method provides strong potential for identify-
ing and characterizing exosomal biomarkers from urine,
which presents favorable implications for the diagnosis and
treatment of chronic kidney disorders.
MATERIALS AND METHODS
Sample collection and urine preprocessing for all the
protocols
Approximately 250ml of first-void urine was collected from four
healthy human volunteers. All subjects provided written informed
consent before participation in the study, which was approved by the
Institutional Review Board of the Translational Genomics Research
Institute. Urine samples were collected in sterile receptacles
containing 3.125ml of protease inhibitor cocktail (Sigma; St Louis,
MO) to reduce protein degradation.9,11 All urine samples were
processed fresh. To eliminate cells and cellular debris from urine
before exosome isolation, samples were preprocessed as shown in
Figure 1.
Urinary exosomes were isolated in duplicate using six different
methods; one of the duplicates was processed for total RNA and
protein extraction, whereas the other was used to quantify urinary
exosome particles. A summary of all protocols is shown in Figure 2,
and a full description of each method is provided in the
Supplementary Information section available online.
Quantification of exosome particles
We quantified and compared the number of urinary exosome
particles using the CD9 ELISA kit (System Biosciences). Exosomes
detected using this kit were derived from renal tubular epithelial
cells of the thick ascending limb where CD9 is expressed.8,26 All
exosome pellets were resuspended in 200ml of Exosome Binding
Buffer (System Biosciences) and processed as per the manufacturer’s
instructions.
Exosomal RNA and protein isolation
Exosome pellets were processed using the DNA/RNA/Protein Mini
and RNeasy MinElute Cleanup kits (Qiagen; Valencia, CA)
according to the manufacturer’s instructions for extraction and
separation of exosomal proteins, small RNAs (o200 nt), and HMW
RNAs (4200 nt) into three fractions from the same sample.
One-dimensional gel electrophoresis, silver stain, and
western blotting
An equal volume (30 ml) of urinary sediment proteins obtained after
the last 17,000 g spin in all the protocols (Figure 1), as well as
exosome pellets and supernatant protein from the final centrifuga-
tion in P5 and P6 (Figure 2), were loaded in each lane of a NuPAGE
Novex 4–12% Bis-Tris gel (Life Technologies; Foster City, CA).
Protein samples were separated by one-dimensional electrophoresis
using a XCell SureLock Mini-Cell apparatus (Life Technologies), and
gels were stained using the ProteoSilver Stain kit (Sigma).
The exosomal protein pellet obtained using the DNA/RNA/
Protein Mini kit was dissolved in 25 ml of reduced sample mix. TSP
was quantified using a Nanodrop Spectrophotometer (Thermo
Scientific, Asheville, NC) and an equal amount of protein (140–
450 ng, Figure 5) was loaded in each lane of a NuPAGE Novex
Table 2 | Summary of the comparison among six different exosome isolation methods
Protocol Based on
Approximate
in-hand time
(min)
miRNA
scorea
mRNA
scorea
Protein
scorea
Exosome
particles
scorea Advantages Disadvantages
P1 Ultracent. 140 4 5 9 5 Very good for proteins; good for
miRNAs and mRNAs
Time consuming; requires ultracent.
P2 Ultracent.+30% suc.
cushion
250 5 4 10 1 Very good for proteins; good for
miRNAs
Time consuming; requires ultracent.
P3 Ultracent.+0.22 mm
filtration
145 1 1 2 1 None Bad for RNA; time consuming;
requires ultracent.
P4 Nanomemb.
ultrafiltration
concentrator
130b 2 1 3 4 No ultracent. Very low purity of protein; not
suitable for RNA
P5 Standard ExoQuick-
TC
45c 5 1 1 2 No ultracent; fast, easy to perform;
excellent to process many samples
at the same time (clinical trials)
Very low purity of proteins; low
exosome yield; bad for RNA
P6 Modified ExoQuick-
TC
70c 10 10 6d 10 Very good for miRNA and mRNA;
good for proteinsd; no ultracent.;
fast, easy to perform; excellent to
process many samples at the same
time (clinical trials)
Low purity of protein, but can be
improved using SECd
Abbreviations: miRNA, microRNA; Nanomemb., nanomembrane; SEC, size-exclusion chromatography; suc., sucrose; ultracent., ultracentrifugation.
aScore from 0 to 10; the higher the number, the higher the efficiency to extract good quality miRNA, high-molecular weight RNA, or protein.
bAdd approximately 3 h for concentration in Speed Vac.
cAdd overnight incubation with ExoQuick-TC at 4 1C.
dProtein score would improve after an extra purification step using gel-size-exclusion chromatography.
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4–12% Bis-Tris gel. Following electrophoresis, gels were transferred
to PVDF (polyvinylidene fluoride) membranes for western blotting.
Membranes were blocked in 0.1% nonfat dry milk dissolved in
1TBST (Tris-buffered saline plus 0.2% v/v Tween-20), probed with
antigen-specific antibodies, and washed with 1TBST solution
using the Snap i.d. Protein Detection System (Millipore) according
to the manufacturer’s instructions. Rabbit polyclonal antibody to
ALIX (1:333) (AIP1: Millipore, Billerica, MA), mouse monoclonal
antibody to TSG101 (1:333) (ab83: Abcam; Cambridge, MA), perox-
idase-conjugated anti-rabbit antibody (1:50,000) (Bio-Rad; Hercules,
CA), and peroxidase-conjugated anti-mouse antibody (1:20,000)
(Jackson Immuno Research; West Grove, PA) were used in the
western blot analysis. The antibody–antigen reactions were visualized
using ECL Prime (GE Healthcare Life Sciences; Piscataway, NJ), and
band density was quantified with the NIH Image J software (http://
rsbweb.nih.gov/ij/).
Quantitative real-time reverse transcriptase–PCR
First-strand cDNA was synthesized from exosomal HMW RNA
obtained by P1–P6 using random primers and the Super Script III
Reverse Transcriptase kit (Life Technologies) according to the
manufacturer’s instructions. The total exosomal small RNA obtained
using P1–P6 was reverse transcribed, half using RNA-specific stem-
looped RT primers for miR-192 and the other half for miR-1207-5p,
in conjunction with the TaqMan MicroRNA Reverse Transcription
kit (Life Technologies). Quantitative real-time reverse transcripta-
se–PCR was performed using commercial TaqMan Gene Expression
Assays (see Supplementary Table S1 online) and the ABI Prism 7900
HT Sequence Detector apparatus (Life Technologies). Results were
analyzed with the qBasePlus v1.5 software (Biogazelle NV; Ghent,
Belgium) using the Relative Quantification with Standard Curve
method, and assuming a 100% efficiency according to the
information supplied by the manufacturer (Life Technologies).
Statistical analysis
All statistical analyses were performed using the software Graph Pad
Prism 5 for Microsoft Windows. Kruskall–Wallis test with a Dunn’s
Multiple Comparison post-test was used to assess differences
between protocols. Results were considered statistically significant
if Po0.05.
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